))
Moving from A to B
Manage episode 320681082 series 3291201
Contenido proporcionado por CCRM. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente CCRM o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Manufacturing and supply chain issues in cell and gene therapies.
Featuring:
Dr. Anthony Davies, Founder and CEO, Dark Horse Consulting
Rob Jones, Vice President, Global Bioservices, Cryoport Systems
It’s no secret that supply chain and manufacturing are crucial to the cell and gene therapy industry, but now the whole world seems to be paying attention. This sudden interest has made Anthony Davies and Rob Jones very popular at dinner parties! Join our guests and CCRM’s host, Krista Lamb, as we delve into some of the big issues related to manufacturing and supply chains. We discuss bringing down COGS, consider the merits of centralized vs. decentralized manufacturing, and contemplate how the industry can scale up to meet the demands of the future, when growth and uptake of cell and gene therapies increases.
Thanks for listening to Commercializing Living Therapies with CCRM. Spread the word about this episode by taking a screen cap on your device and posting it to social media using the hashtag #CCRMpodcast. Please leave us a review on your favourite streaming service. Find more episodes at ccrm.ca/podcast.
21 episodios
Compartir
